<DOC>
	<DOCNO>NCT00000998</DOCNO>
	<brief_summary>To evaluate safety effectiveness trimetrexate ( TMTX ) give increase dos along leucovorin calcium ( LCV ) treat Pneumocystis carinii pneumonia ( PCP ) AIDS patient TMTX experimental new drug effective treatment PCP , give patient . Therefore certain TMTX better , , effective conventional drug PCP .</brief_summary>
	<brief_title>A Study Trimetrexate Treatment Pneumocystis Carinii Pneumonia ( PCP ) Patients With AIDS Not Previously Treated PCP</brief_title>
	<detailed_description>TMTX experimental new drug effective treatment PCP , give patient . Therefore certain TMTX better , , effective conventional drug PCP . Increasing dos TMTX use combination LCV initial treatment PCP 50 AIDS patient . Doses increase 21 day daily twice daily basis . Dose escalation occur subsequent group patient .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Trimetrexate</mesh_term>
	<criteria>Inclusion Criteria Patient must : Have Pneumocystis carinii pneumonia ( PCP ) treat current episode . PCP must document observation &gt; 1 cluster organism sputum , bronchial secretion , lung tissue . Have clinical symptom respiratory disease radiologic abnormality . Exclusion Criteria Patient significant emotional disorder . Concurrent Medication : Excluded : Drugs likely bone marrow toxic . Investigational drug . Prior Medication : Excluded : Three patient group zidovudine ( AZT ) least 2 month prior administration trimetrexate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Trimetrexate</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Injections , Intravenous</keyword>
	<keyword>Leucovorin</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Folic Acid Antagonists</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antineoplastic Agents</keyword>
</DOC>